KWS SAAT SE & Co. KGaA (KWS)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 67.00 |
|---|---|
| 52-week range | 62.10 – 80.60 |
| Return, 1 month / 3 months | −6.3% / −7.7% |
| Return, 1 year / 3 years | −0.5% / +37.1% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 24.4% |
| Worst drawdown (1 year) | -17.4% |
| Average daily value traded | 0.88M EUR |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KWS SAAT SE & Co. KGaA is a plant breeding and seed company based in Einbeck, Germany. It develops and markets seeds for sugar beet, maize, cereals and other agricultural crops, and also offers varieties for vegetables and oilseed rape. Its customers are farmers and agricultural businesses, and it operates breeding and sales activities in many countries. The company combines classical plant breeding with modern breeding methods to produce seed varieties suited to different growing conditions.
KWS SAAT SE & Co. KGaA trades under the code KWS on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KWS SAAT SE & Co. KGaA (KWS) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 67.00 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 252 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.5% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.3% | ||
| From 52-week high | -16.1% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -9.3% | ||
| 12-month return, skipping the last month | 6.2% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.4% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.88M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −6.3% |
| 3 months | −7.7% |
| 6 months | −9.3% |
| 1 year | −0.5% |
| 3 years | +37.1% |
| 5 years | −3.1% |
Signals
| 50-day / 200-day average | 72.92 / 71.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.15 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Dec 2025 | EUR 1.2500 |
| 6 Dec 2024 | EUR 1.0000 |
| 14 Dec 2023 | EUR 0.9000 |
| 7 Dec 2022 | EUR 0.8000 |
| 3 Dec 2021 | EUR 0.8000 |
| 17 Dec 2020 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.